AACPN Launches Psychedelic Research Initiative to Advance Veteran Mental Health Innovation
The American Alternative Care Policy Network (AACPN) this week launched its Psychedelic Research Initiative to support continued scientific research into emerging therapies that may help address some of America's most difficult mental health challenges. At the center of this effort are veterans. For many veterans, the invisible wounds of service can persist long after they return home. Post-traumatic stress, depression, anxiety, traumatic brain injury, substance-use disorders
AACPN Applauds Connecticut Enactment of Public Act 26-108 Expanding Psychedelic-Assisted Therapy Research
AACPN applauds Connecticut’s enactment of Public Act 26-108, expanding the state’s psychedelic-assisted therapy pilot program and supporting continued clinical research involving MDMA and psilocybin therapies for veterans, first responders, trauma survivors, and individuals living with treatment-resistant mental health conditions.
AACPN Statement on VA MDMA-Assisted Therapy Trial
AACPN welcomes the U.S. Department of Veterans Affairs’ launch of a clinical trial evaluating MDMA-assisted therapy for veterans living with PTSD and alcohol use disorder. The organization says rigorous scientific research is essential to understanding whether emerging therapies can safely and effectively support veterans and other trauma survivors facing complex behavioral health challenges.
AACPN Opposes Federal Ban on Hemp-Derived THC Beverages, Calls for Responsible Regulation
The American Alternative Care Policy Network has launched a new initiative opposing upcoming federal restrictions on hemp-derived THC beverages and advocating for responsible, science-based regulation focused on consumer safety, harm reduction, trauma recovery, and evidence-based alternative care policy.